IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational ...

Shares of IGC Pharma, Inc. (NYSEMKT:IGC – Get Free Report) were down 7.4% on Thursday .The stock traded as low as $0.32 and last traded at $0.30. Approximately 214,616 shares changed hands ...